Age-related macular degeneration (AMD) is the leading cause of permanent vision loss in Americans over 50 — and it often steals your central vision silently, without pain or warning, before most seniors realize anything is wrong. More than 11 million Americans currently have AMD, and that number is projected to reach 22 million by 2050 as the population ages. The good news: 2026 brings better treatment options than ever before, and early intervention can preserve your vision for years. Here’s everything seniors need to know about macular degeneration prevention, detection, and treatment — including what Medicare covers.
What Is Age-Related Macular Degeneration?
The macula is the small central portion of your retina — the light-sensitive tissue at the back of your eye. It’s responsible for the sharp, detailed central vision you need for reading, recognizing faces, driving, and seeing fine detail. When the macula deteriorates with age, you lose the ability to see straight ahead clearly, even if your peripheral vision remains intact.
AMD comes in two forms:
| Type | Description | Progression | Treatment |
|---|---|---|---|
| Dry AMD (atrophic) | Gradual breakdown of light-sensitive cells in the macula; accounts for 85-90% of cases | Slow over years | AREDS2 supplements; no drug cure yet |
| Wet AMD (neovascular) | Abnormal blood vessels grow under the retina, leak fluid and blood | Rapid — can cause severe loss in weeks | Anti-VEGF injections (highly effective) |
Approximately 10-15% of dry AMD cases progress to wet AMD over time. When wet AMD develops, it’s a medical emergency requiring immediate treatment.
Macular Degeneration Risk Factors: Are You at High Risk?
Understanding your risk profile is the first step to protecting your vision. The major risk factors for AMD include:
- Age: Risk increases dramatically after 60; adults 75+ have a 30% prevalence rate
- Smoking: Current smokers have 3-4x higher AMD risk — the single most modifiable risk factor
- Family history: Having a first-degree relative with AMD doubles your risk
- Race: Caucasians are at significantly higher risk than African Americans or Hispanics
- Obesity: BMI over 30 is associated with faster AMD progression
- Cardiovascular disease: Hypertension and high cholesterol accelerate macular deterioration
- UV exposure: Lifetime sunlight exposure without protection increases cumulative retinal damage
- Genetics: The CFH gene variant (present in ~40% of people) significantly elevates AMD risk
Warning Signs of AMD Every Senior Must Know
AMD often has no pain and minimal early symptoms — which is why routine eye exams are so critical. Watch for these warning signs:
- Blurry or fuzzy central vision when reading or watching TV
- Straight lines appearing wavy or distorted (use the Amsler Grid test daily — free printable at nei.nih.gov)
- A dark, blurry spot or “blind spot” in the center of your vision
- Colors appearing less vivid or bright
- Needing more light to see clearly
- Difficulty recognizing faces even up close
If you notice any sudden change in central vision, call your ophthalmologist immediately — wet AMD can progress from minor to devastating vision loss within days.
The AREDS2 Formula: What Research Proves Works for Dry AMD
The Age-Related Eye Disease Study 2 (AREDS2), conducted by the National Eye Institute, is the gold standard for dry AMD supplementation. For seniors with intermediate AMD or advanced AMD in one eye, the AREDS2 formula reduces the risk of progression to advanced AMD by 25%.
The proven AREDS2 formulation includes:
- Vitamin C: 500 mg
- Vitamin E: 400 IU
- Lutein: 10 mg
- Zeaxanthin: 2 mg
- Zinc: 80 mg (as zinc oxide)
- Copper: 2 mg (as cupric oxide)
Important: AREDS2 supplements are NOT recommended for early AMD or for people without AMD — they only benefit intermediate and advanced cases. Do not take them without an ophthalmologist’s recommendation.
Wet AMD Treatments in 2026: Anti-VEGF Injections and New Options
Wet AMD treatment has been transformed by anti-VEGF (anti-vascular endothelial growth factor) therapy. These injections, delivered directly into the eye by a retinal specialist, block the abnormal blood vessel growth that causes wet AMD. When started promptly, they can stabilize or even improve vision in the majority of patients.
Current FDA-approved anti-VEGF treatments in 2026:
- Eylea (aflibercept): Standard every-8-week dosing after monthly loading doses; the most widely used
- Eylea HD (high-dose aflibercept): Approved 2023; allows up to every-16-week dosing intervals — reducing injection burden
- Lucentis (ranibizumab): Monthly dosing; biosimilars now available, reducing cost
- Vabysmo (faricimab): Dual-action (anti-VEGF and anti-Ang-2); up to every-16-week intervals for qualifying patients
- Susvimo implant: A refillable port device surgically implanted in the eye that delivers continuous anti-VEGF treatment — reduces need for injections to twice yearly in some patients
Medicare Coverage for AMD: What’s Covered in 2026
Here’s the Medicare coverage breakdown for AMD-related services in 2026:
| Service | Medicare Coverage | What You Pay |
|---|---|---|
| Anti-VEGF injections (Eylea, Lucentis) | Part B covers 80% | 20% coinsurance after $283 deductible |
| Retinal exams (medically necessary) | Part B covers 80% | 20% coinsurance |
| OCT (optical coherence tomography) imaging | Part B covers 80% | 20% coinsurance |
| Glaucoma screening (high-risk patients) | Part B covers 80% | 20% coinsurance |
| Routine eye exams | NOT covered by Original Medicare | 100% out of pocket or Medicare Advantage |
| Eyeglasses/contacts | NOT covered (except post-cataract) | Medicare Advantage vision benefit may help |
Medigap Plan G will cover the 20% Part B coinsurance for anti-VEGF injections, which can become substantial for seniors requiring injections every 4-8 weeks.
7 Science-Backed Steps to Protect Your Vision and Slow AMD
- Get a comprehensive dilated eye exam every 1-2 years after age 65. AMD has no early symptoms — only a dilated exam can detect drusen (early AMD deposits) before vision loss begins.
- Quit smoking immediately. Smoking is the only modifiable risk factor that has the largest independent impact on AMD development and progression. Even quitting after age 65 reduces risk significantly within 5 years.
- Eat lutein and zeaxanthin-rich foods daily. Kale, spinach, and eggs are the top sources of these macular-protective carotenoids. Aim for 6-10 mg lutein daily.
- Wear UV-blocking sunglasses outdoors. Choose wraparound frames with 99-100% UVA/UVB protection. This is especially important in high-altitude and coastal environments.
- Control blood pressure and cholesterol. Vascular disease accelerates AMD progression. A blood pressure under 130/80 mmHg and LDL under 100 mg/dL are protective targets.
- Exercise regularly. A study in the British Journal of Ophthalmology found that 2.5+ hours of moderate exercise per week was associated with 70% lower risk of wet AMD progression.
- Use the Amsler Grid daily. This simple at-home test (a grid of straight lines) can detect early distortion from wet AMD — allowing prompt treatment that can save your central vision.
The Bottom Line on Macular Degeneration in Seniors
Age-related macular degeneration is not an inevitable part of aging. With regular dilated eye exams, the right nutrition strategy, smoking cessation, and — when needed — prompt treatment with anti-VEGF injections, most seniors can preserve their central vision well into their 80s and beyond. If you haven’t had a dilated eye exam recently, make that appointment today. The vision you save may be your own.
Sources: National Eye Institute — AMD | Medicare.gov — Eye Care Coverage | American Academy of Ophthalmology
Related Articles You May Find Helpful
- Hearing Loss & Dementia Risk: What Seniors Must Know in 2026
- Vitamin D & Alzheimer’s Risk: What Every Senior Must Know in 2026
- MIND Diet for Seniors 2026: Eat Your Way to a Sharper Brain
- Osteoporosis Prevention for Seniors in 2026: 5 Proven Pillars
- Best Medigap Plans 2026: Which Medicare Supplement Saves Most?